Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin
Introduction | Browse | Search | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | TxB2 | cPLA2i | 1.0 | BCD110605C16 | 5.64 | pmol/ml of medium |
| - | TxB2 | cPLA2i | 1.0 | BCD110605C18 | 6.39 | pmol/ml of medium |
| - | TxB2 | cPLA2i | 1.0 | BCD110605C17 | 5.41 | pmol/ml of medium |
| - | TxB2 | cPLA2i | 4.0 | BCD110605C34 | 5.62 | pmol/ml of medium |
| - | TxB2 | cPLA2i | 4.0 | BCD110605C36 | 5.32 | pmol/ml of medium |
| - | TxB2 | cPLA2i | 4.0 | BCD110605C35 | 6.5 | pmol/ml of medium |
| - | TxB2 | cPLA2i | 20.0 | BCD110605C53 | 5.88 | pmol/ml of medium |
| - | TxB2 | cPLA2i | 20.0 | BCD110605C54 | 6.33 | pmol/ml of medium |
| - | TxB2 | cPLA2i | 20.0 | BCD110605C52 | 6.01 | pmol/ml of medium |
| - | TxB2 | PLDi | 1.0 | BCD110605C10 | 6.27 | pmol/ml of medium |
| - | TxB2 | PLDi | 1.0 | BCD110605C12 | 6.41 | pmol/ml of medium |
| - | TxB2 | PLDi | 1.0 | BCD110605C11 | 6.24 | pmol/ml of medium |
| - | TxB2 | PLDi | 4.0 | BCD110605C30 | 5.31 | pmol/ml of medium |
| - | TxB2 | PLDi | 4.0 | BCD110605C29 | 5.85 | pmol/ml of medium |
| - | TxB2 | PLDi | 4.0 | BCD110605C28 | 5.79 | pmol/ml of medium |
| - | TxB2 | PLDi | 20.0 | BCD110605C48 | 5.52 | pmol/ml of medium |
| - | TxB2 | PLDi | 20.0 | BCD110605C47 | 5.73 | pmol/ml of medium |
| - | TxB2 | PLDi | 20.0 | BCD110605C46 | 5.96 | pmol/ml of medium |
| - | TxB2 | KDO+cPLA2i | 1.0 | BCD110605C19 | 6.29 | pmol/ml of medium |
| - | TxB2 | KDO+cPLA2i | 1.0 | BCD110605C21 | 6.86 | pmol/ml of medium |
| - | TxB2 | KDO+cPLA2i | 1.0 | BCD110605C20 | 8.05 | pmol/ml of medium |
| - | TxB2 | KDO+cPLA2i | 4.0 | BCD110605C39 | 3.22 | pmol/ml of medium |
| - | TxB2 | KDO+cPLA2i | 4.0 | BCD110605C37 | 7.25 | pmol/ml of medium |
| - | TxB2 | KDO+cPLA2i | 4.0 | BCD110605C38 | 7.28 | pmol/ml of medium |
| - | TxB2 | KDO+cPLA2i | 20.0 | BCD110605C55 | 9.22 | pmol/ml of medium |
| - | TxB2 | KDO+cPLA2i | 20.0 | BCD110605C57 | 9.54 | pmol/ml of medium |
| - | TxB2 | KDO+cPLA2i | 20.0 | BCD110605C56 | 8.99 | pmol/ml of medium |
| - | TxB2 | KDO+PLDi | 1.0 | BCD110605C15 | 8.86 | pmol/ml of medium |
| - | TxB2 | KDO+PLDi | 1.0 | BCD110605C14 | 11.2 | pmol/ml of medium |
| - | TxB2 | KDO+PLDi | 1.0 | BCD110605C13 | 8.75 | pmol/ml of medium |
| - | TxB2 | KDO+PLDi | 4.0 | BCD110605C32 | 10.4 | pmol/ml of medium |
| - | TxB2 | KDO+PLDi | 4.0 | BCD110605C31 | 9.3 | pmol/ml of medium |
| - | TxB2 | KDO+PLDi | 4.0 | BCD110605C33 | 10.4 | pmol/ml of medium |
| - | TxB2 | KDO+PLDi | 20.0 | BCD110605C49 | 15.6 | pmol/ml of medium |
| - | TxB2 | KDO+PLDi | 20.0 | BCD110605C51 | 15.6 | pmol/ml of medium |
| - | TxB2 | KDO+PLDi | 20.0 | BCD110605C50 | 13.8 | pmol/ml of medium |
| - | TxB2 | KDO + ATP | 1.0 | BCD110605C07 | 9.77 | pmol/ml of medium |
| - | TxB2 | KDO + ATP | 1.0 | BCD110605C09 | 9.69 | pmol/ml of medium |
| - | TxB2 | KDO + ATP | 1.0 | BCD110605C08 | 8.94 | pmol/ml of medium |
| - | TxB2 | KDO + ATP | 4.0 | BCD110605C25 | 12 | pmol/ml of medium |
| - | TxB2 | KDO + ATP | 4.0 | BCD110605C26 | 11.1 | pmol/ml of medium |
| - | TxB2 | KDO + ATP | 4.0 | BCD110605C27 | 11.4 | pmol/ml of medium |
| - | TxB2 | KDO + ATP | 20.0 | BCD110605C45 | 17.4 | pmol/ml of medium |
| - | TxB2 | KDO + ATP | 20.0 | BCD110605C43 | 12.9 | pmol/ml of medium |
| - | TxB2 | KDO + ATP | 20.0 | BCD110605C44 | 14.4 | pmol/ml of medium |
| - | TxB2 | C | 0.0 | BCD110605C02 | 5.23 | pmol/ml of medium |
| - | TxB2 | C | 0.0 | BCD110605C01 | 5.93 | pmol/ml of medium |
| - | TxB2 | C | 0.0 | BCD110605C03 | 6.72 | pmol/ml of medium |
| - | TxB2 | C | 1.0 | BCD110605C06 | 5.76 | pmol/ml of medium |
| - | TxB2 | C | 1.0 | BCD110605C05 | 6.3 | pmol/ml of medium |